Cardiac Contractility Modulation Therapy in Amyloid Cardiomyopathy Patients With Heart Failure
Condition(s):Amyloidosis Cardiac; Heart FailureLast Updated:December 22, 2021Recruiting
Include Studies Not Open or Pending
Condition(s):Amyloidosis Cardiac; Heart FailureLast Updated:December 22, 2021Recruiting
Condition(s):Heart Failure NYHA Class II; Heart Failure NYHA Class IIILast Updated:March 27, 2024Recruiting
Condition(s):Heart FailureLast Updated:February 8, 2023Not yet recruiting
Condition(s):Chronic Heart FailureLast Updated:June 5, 2023Recruiting
Condition(s):Heart FailureLast Updated:July 28, 2023Recruiting
Condition(s):Heart FailureLast Updated:August 14, 2023Not yet recruiting
Condition(s):Cardiovascular Diseases; Heart Failure With Reduced Ejection FractionLast Updated:January 18, 2024Not yet recruiting
Condition(s):Heart Failure; Heart Failure AcuteLast Updated:March 6, 2024Recruiting
Condition(s):Congestive Heart FailureLast Updated:November 24, 2023Not yet recruiting
Condition(s):Heart Failure CongenitalLast Updated:September 15, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.